Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis
Open Access
- 2 May 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (5) , e0154512
Abstract
IFN orchestrates the expression of various genes to halt hepatitis C virus (HCV) replication with the possibility of either reduced or increased liver fibrosis; due to controlled viral replication or overproduction of inflammatory mediators, repectively. In this study, we examined the transcriptional profiling of type I IFN related genes in HCV-chronically infected patients with varying degrees of liver fibrosis. PCR array was used to examine the expression of 84 type I IFN related genes in peripheral blood mononuclear cells (PBMCs) RNA from 12 treatment-naïve chronic HCV patients (5 F0-F1 and 7 F2-F4) and 5 healthy subjects. We further validated our results by quantitative real time PCR (qRT-PCR) in 103 treatment-naïve chronic HCV patients (43 F0-F1 and 60 F2-F4) and 15 controls. PCR array data revealed dysregulation in TLR7 pathway. The expression of TLR7 was decreased by 4 folds and MyD88 was increased by 3 folds in PBMCs of F2-F4 patients when compared to the healthy volunteers (p = 0.03 and 0.002, respectively). In addition, IRF7 and TLR7 showed dramatic downregulation (6 and 8 folds, respectively) in F2-F4 patients when compared to F0-F1 ones. qRT-PCR confirmed the altered expression patterns of TLR7 and MyD88 in F2-F4 patients when compared to either controls or F0-F1 patients. However, by qRT-PCR, IRF7 and NF-κB1 (TLR7 pathway transcription factors) exhibited similar mRNA abundance among F2-F4 and F0-F1 patients. These results suggest that TLR7 and MyD88 are possible candidates as biomarkers for the progression of HCV-induced liver fibrosis and/ or targets for therapeutic intervention.Keywords
Funding Information
- Science and Technology Development Fund in Egypt (STDF) (3365)
This publication has 50 references indexed in Scilit:
- Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver DiseaseHepatitis Monthly, 2012
- IL28B Genotype Is Associated With Differential Expression of Intrahepatic Interferon-Stimulated Genes in Patients With Chronic Hepatitis CHepatology, 2010
- Plasmacytoid dendritic cells sense hepatitis C virus–infected cells, produce interferon, and inhibit infectionProceedings of the National Academy of Sciences, 2010
- Expert opinion on the treatment of patients with chronic hepatitis CJournal of Viral Hepatitis, 2009
- Interferon-inducible antiviral effectorsNature Reviews Immunology, 2008
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Reduced liver injury in the interleukin‐6 knockout mice by chronic carbon tetrachloride administrationEuropean Journal of Clinical Investigation, 2008
- Serial changes in expression of functionally clustered genes in progression of liver fibrosis in hepatitis C patientsWorld Journal of Gastroenterology, 2008
- Investigating Toll-Like Receptor Agonists for Potential To Treat Hepatitis C Virus InfectionAntimicrobial Agents and Chemotherapy, 2007
- Changes in Gene Expression during Pegylated Interferon and Ribavirin Therapy of Chronic Hepatitis C Virus Distinguish Responders from Nonresponders to Antiviral TherapyJournal of Virology, 2007